{
    "clinical_study": {
        "@rank": "73918", 
        "arm_group": [
            {
                "arm_group_label": "Group BT", 
                "description": "Bupivacaine-tramadol (BT) group received a caudal injection of bupivacaine 0.25% plus tramadol 2 mg/kg"
            }, 
            {
                "arm_group_label": "Group LT", 
                "description": "Levobupivacaine-tramadol (LT) group received a caudal injection of levobupivacaine 0.25% plus tramadol 2 mg/kg, resulting in a total volume of 1 ml/kg."
            }
        ], 
        "brief_summary": {
            "textblock": "Caudal block is the regional anesthetic technique that is used most frequently in pediatric\n      surgery. Opioid drugs have been added to local anesthetic solutions to prolong duration of\n      analgesia but ideal combination were not found that has minimal adverse effect. The aim of\n      this study was to compare the postoperative analgesic efficacy of equal concentrations of\n      bupivacaine plus tramadol or levobupivacaine plus tramadol in pediatric patients undergoing\n      minor urological surgery."
        }, 
        "brief_title": "Caudal Block With Tramadol and Levobupivacaine or Bupivacaine", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pain, Postoperative", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "Sixty-eight children aged 2 to 7 years who were undergoing inguinal herniorrhaphy or\n      orchidopexy received bupivacaine 0.25% plus tramadol 2 mg/kg (BT group) or levobupivacaine\n      0.25% plus tramadol 2 mg/kg (LT group) by the caudal route after laryngeal mask anesthesia.\n      The primary outcome of the study was to compare the duration and quality of postoperative\n      analgesia. The postoperative pain relief was evaluated by the Children and Infants\n      Postoperative Pain Scale (CHIPPS) at 2, 4, 6, 12, and 24 h postoperatively. In addition, the\n      time of first analgesic requirement was noted."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I,\n\n          -  2 to 7 years old children\n\n          -  Elective inguinal herniorrhaphy or orchidopexy operation\n\n        Exclusion Criteria:\n\n          -  Infection at the site of block, bleeding diathesis, pre-existing neurological or\n             spinal disease, or abnormalities of the sacrum) or with a known allergy to local\n             anesthetics were excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "7 Years", 
            "minimum_age": "2 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "ASA status I children aged 2 to 7 years who were scheduled for elective inguinal\n        herniorrhaphy or orchidopexy were enrolled."
            }
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974843", 
            "org_study_id": "DZC-160"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group LT", 
                "description": "in the levobupivacaine-tramadol (LT) group received a caudal injection of levobupivacaine 0.25% plus tramadol 2 mg/kg (maximum doses; 35 mg levobupivacaine plus 35 mg tramadol), resulting in a total volume of 1 ml/kg at maximum volume of 15 ml", 
                "intervention_name": "Levobupivacaine", 
                "intervention_type": "Drug", 
                "other_name": "Chirocaine, Abbott Lab, Nycomed Pharma, Norway"
            }, 
            {
                "arm_group_label": "Group BT", 
                "description": "in the bupivacaine-tramadol (BT) group received a caudal injection of bupivacaine 0.25% plus tramadol 2 mg/kg (maximum doses; 35 mg bupivacaine plus 35 mg tramadol)", 
                "intervention_name": "Bupivacaine", 
                "intervention_type": "Drug", 
                "other_name": "Marcaine, Astra Zeneca, UK"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Levobupivacaine", 
                "Tramadol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 6, 2014", 
        "link": [
            {
                "description": "caudal block usage in pediatric patients", 
                "url": "http://www.paccjournal.com/"
            }, 
            {
                "description": "performing of caudal block in pediatric patients", 
                "url": "http://www.nysora.com/"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Duzce", 
                    "country": "Turkey", 
                    "zip": "81620"
                }, 
                "name": "Duzce University Medicine School, Anesthesiology and Reanimation Department"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Assessment of Bupivacaine-tramadol and Levobupivacaine-tramadol Combinations for Preemptive Caudal Anaesthesia in Children: a Randomized, Double-blind, Prospective Study", 
        "other_outcome": {
            "description": "In the case of a CHIPPS score of 4 or more, paracetamol 30 mg.kg -1 was administered rectally. The duration of analgesia was defined by noting the time from caudal injection to the time of first analgesic requirement.", 
            "measure": "first analgesic requirement", 
            "safety_issue": "No", 
            "time_frame": "Postoperatively 24 h"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The postoperative pain relief was evaluated by the Children and Infants Postoperative Pain Scale (CHIPPS) at 2, 4, 6, 12, and 24 h postoperatively. In addition, the time of first analgesic requirement was noted.", 
            "measure": "Quality of postoperative analgesia", 
            "safety_issue": "No", 
            "time_frame": "Postopertively 24 h"
        }, 
        "reference": [
            {
                "PMID": "16682915", 
                "citation": "Silvani P, Camporesi A, Agostino MR, Salvo I. Caudal anesthesia in pediatrics: an update. Minerva Anestesiol. 2006 Jun;72(6):453-9. Review."
            }, 
            {
                "PMID": "15608043", 
                "citation": "Locatelli B, Ingelmo P, Sonzogni V, Zanella A, Gatti V, Spotti A, Di Marco S, Fumagalli R. Randomized, double-blind, phase III, controlled trial comparing levobupivacaine 0.25%, ropivacaine 0.25% and bupivacaine 0.25% by the caudal route in children. Br J Anaesth. 2005 Mar;94(3):366-71. Epub 2004 Dec 17. PubMed PMID: 15608043."
            }, 
            {
                "PMID": "20412459", 
                "citation": "Yildiz TS, Ozdamar D, Bagus F, Solak M, Toker K. Levobupivacaine-tramadol combination for caudal block in children: a randomized, double-blinded, prospective study. Paediatr Anaesth. 2010 Jun;20(6):524-9. doi: 10.1111/j.1460-9592.2010.03296.x. Epub 2010 Apr 14."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974843"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Duzce University", 
            "investigator_full_name": "gulbin sezen", 
            "investigator_title": "assistant of professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "All patients were observed in the hospital for at least 24 h because of the possible side effects of caudal blocks.", 
            "measure": "Adverse effect", 
            "safety_issue": "No", 
            "time_frame": "Postoperatively at 2, 4, 6, 12, and 24 h"
        }, 
        "source": "Duzce University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duzce University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Day", 
        "verification_date": "February 2014"
    }
}